4.8 Article

Allosteric inhibition of kinesin-5 modulates its processive directional motility

Journal

NATURE CHEMICAL BIOLOGY
Volume 2, Issue 9, Pages 480-485

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio812

Keywords

-

Funding

  1. NIGMS NIH HHS [GM65933] Funding Source: Medline

Ask authors/readers for more resources

Small-molecule inhibitors of kinesin-5 (refs. 1-3), a protein essential for eukaryotic cell division(4), represent alternatives to antimitotic agents that target tubulin(5,6). While tubulin is needed for multiple intracellular processes, the known functions of kinesin-5 are limited to dividing cells, making it likely that kinesin-5 inhibitors would have fewer side effects than do tubulin-targeting drugs. Kinesin-5 inhibitors, such as monastrol(1), act through poorly understood allosteric mechanisms, not competing with ATP binding(7,8). Moreover, the microscopic mechanism of full-length kinesin-5 motility is not known. Here we characterize the motile properties and allosteric inhibition of Eg5, a vertebrate kinesin-5, using a GFP fusion protein in single-molecule fluorescence assays(9). We find that Eg5 is a processive kinesin whose motility includes, in addition to ATP-dependent directional motion, a diffusive component not requiring ATP hydrolysis. Monastrol suppresses the directional processive motility of microtubule-bound Eg5. These data on Eg5' s allosteric inhibition will impact these inhibitors' use as probes and development as chemotherapeutic agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available